Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Cells|July 12, 2024
Navigating the Neurobiology of Migraine: From Pathways to Potential TherapiesMasaru Tanaka, Bernadett Tuka, László VécseiIdeggyogyaszati Szemle|June 30, 2015
OLD AND NEW NEUROENDOCRINE MOLECULES: SOMATOSTATIN, CYSTEAMINE, PANTETHINE AND KYNURENINELászló Vécsei, Zoltán Horváth, Bernadett TukaCurrent Alzheimer Research|May 29, 2015
Alzheimer's disease, astrocytes and kynureninesLivia Dezsi, Bernadett Tuka, Diana Martos, et al.Biomedicines|April 23, 2022
Memory Enhancement with Kynurenic Acid and Its Mechanisms in NeurotransmissionDiána Martos, Bernadett Tuka, Masaru Tanaka, et al.CNS & Neurological Disorders Drug Targets|April 30, 2015
Role of pituitary adenylate cyclase-activating polypeptide in nociception and migraineJanos Tajti, Bernadett Tuka, Balint Botz, et al.The Journal of Headache and Pain|May 1, 2019
The effect of orofacial complete Freund's adjuvant treatment on the expression of migraine-related moleculesTamás Körtési, Bernadett Tuka, Aliz Nyári, et al.Brain Research|January 3, 2012
Calcitonin gene-related peptide and its receptor components in the human sphenopalatine ganglion -- interaction with the sensory systemAnett Csati, Janos Tajti, Bernadett Tuka, et al.Neuropeptides|June 22, 2015
Migraine and neuropeptidesJános Tajti, Délia Szok, Zsófia Majláth, et al.Frontiers in Neurology|February 2, 2018
Kynurenic Acid Inhibits the Electrical Stimulation Induced Elevated Pituitary Adenylate Cyclase-Activating Polypeptide Expression in the TNCTamás Körtési, Bernadett Tuka, János Tajti, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|January 15, 2018
Kynurenic acid and its derivatives are able to modulate the adhesion and locomotion of brain endothelial cellsEszter Lajkó, Bernadett Tuka, Ferenc Fülöp, et al.Pageof 4